CERAXON PLUS owner Contact Information online
from FERRER INTERNACIONAL, S.A.
CERAXON PLUS
US serial number:85010217
Application filling date:Apr. 09, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Feb. 03, 2014
Publication date:Nov. 02, 2010
Abandoned date:Feb. 03, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Nutraceuticals for enhancing energy and well being, and for weight loss; Nutraceuticals for use as a dietary supplement
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:Nutraceuticals for enhancing energy and well being
and for weight loss; Nutraceuticals for use as a dietary supplement
Current owner owner name:FERRER INTERNACIONAL, S.A.
Current owner owner address:Gran Vía de Carlos III, 94
08028 Barcelona
SPAIN
Current owner legal entity type:sociedad anonima (sa)
Current owner state or country:SPAIN
Attorney name:David E. Weslow
Attorney email:eteas@sutherland.com
Attorney docket number:25220-0027
Attorney email authorized:Yes
Correspondent name address:David E. Weslow
Wiley Rein LLP
1776 K Street, N.W.
Washington,
DISTRICT OF COLUMBIA
UNITED STATES
20006
Correspondent phone:202.719.7525
Correspondent email:dweslow@wileyrein.com
Correspondent fax:202.719.7049
Correspondent email authorized:Yes
Domestic representative name:David E. Weslow
Domestic representative phone:202.719.7525
Domestic representative fax:202.719.7049
Domestic representative email:eteas@sutherland.com
Domestic representative email authorized:Yes
Trademark staff tm attorney:KEATING, MICHAEL P
Trademark staff law office assigned CERAXON PLUS:LAW OFFICE 101
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (132) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (49) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Nov. 02, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
